Bitter taste receptors (T2Rs) are GPCRs involved in detection of bitter compounds by type 2 taste cells of the tongue, but are also expressed in other tissues throughout the body, including the airways, gastrointestinal tract, and brain. These T2Rs can be activated by several bacterial products and regulate innate immune responses in several cell types. Expression of T2Rs has been demonstrated in immune cells like neutrophils; however, the molecular details of their signaling are unknown. We examined mechanisms of T2R signaling in primary human monocyte-derived unprimed (M0) macrophages (MFs) using live cell imaging techniques. Known bitter compounds and bacterial T2R agonists activated low-level calcium signals through a pertussis toxin (PTX)-sensitive, phospholipase C-dependent, and inositol trisphosphate receptor-dependent calcium release pathway. These calcium signals activated low-level nitric oxide (NO) production via endothelial and neuronal NO synthase (NOS) isoforms. NO production increased cellular cGMP and enhanced acute phagocytosis ~3-fold over 30-60 min via protein kinase G. In parallel with calcium elevation, T2R activation lowered cAMP, also through a PTX-sensitive pathway. The cAMP decrease also contributed to enhanced phagocytosis. Moreover, a co-culture model with airway epithelial cells demonstrated that NO produced by epithelial cells can also acutely enhance MF phagocytosis. Together, these data define MF T2R signal transduction and support an immune recognition role for T2Rs in MF cell physiology.
Introduction
Taste family 2 receptors (T2Rs) are GPCRs involved in bitter taste perception on the tongue [1, 2] .
However, T2Rs are expressed throughout the body, including the nose and sinuses [3, 4] and lung [5] . T2Rs canonically decrease cAMP via Ga-gustducin (Gagust) or Gai [6, 7] and Gbg activation of phospholipase C (PLC), production of IP3, and elevation of calcium ( Fig 1B) [3] . There are 25 T2Rs on the human tongue [1] .
Nasal ciliated epithelial cells express T2Rs 4, 14, 16, 38 , and possibly others. In addition to their canonical role in taste, mounting evidence suggests T2Rs are bona fide immune recognition receptors for chemosensation of bacteria. Cilia T2Rs detect bacterial products and activate local defense responses within seconds [7, 8] ,
including Ca 2+ -dependent nitric oxide (NO) production that increases ciliary beating and has direct antibacterial effects [8, 9] . T2R38, T2R10, and T2R14 respond to bacterial acyl-homoserine lactone (AHL) quorum-sensing molecules [9] [10] [11] . T2Rs 4, 16 , and 38 respond to Pseudomonas quinolone signal (PQS), and T2R14 responds to heptyl-hydroxyquinolone (HHQ) secreted by Pseudomonas [7] .
Clinical importance of extraoral T2Rs in immunity is supported by correlation of polymorphisms rendering T2R38 non-functional with susceptibility to chronic rhinosinusitis CRS [9, [12] [13] [14] [15] [16] [17] . A high number of T2R polymorphisms exist, contributing to individual taste preferences, but possibly also contributing to susceptibility to infection. It is critical to elucidate mechanisms of extraoral chemosensation by T2Rs to understand if and how to target T2Rs to activate innate immune responses.
Dedicated immune cells also express T2Rs [18] [19] [20] [21] . T2R38 detects AHLs in neutrophils [18, 19] and is expressed in both resting and activated lymphocytes [20] . Circulating human monocytes, natural killer (NK) cells, B cells, T cells, and polymorphonuclear (PMN) leukocytes also express T2Rs [21] . Stimulation of PMNs with saccharin, which activates both T2Rs and T1R2/3 sweet receptors, enhanced leukocyte migration [21] .
However, our understanding of the details of T2R signaling and physiological consequences in immune cells are limited.
Our goal was to determine if T2Rs in primary human macrophages (MFs) are coupled to calcium and if this activates NO as in airway epithelial cells. MFs are important players in early innate immune responses, and unprimed (M0) MFs express Ca 2+ -activated endothelial (e) and/or neuronal (n) nitric oxide synthase (NOS) isoforms, though studies of e/nNOS in MF function are limited. The majority of studies of NO in MFs focuses on higher level NO production via upregulation of inducible iNOS in LPS ± IFNg-activated (classically-activated or M1) MFs and the relationship of the NO to bacterial killing or metabolism [22] . However, iNOS is not expressed or is expressed at very low levels in monocytes and unstimulated M0 MFs [22] , while eNOS and/or nNOS are expressed [23] [24] [25] [26] [27] [28] and can be activated by calcium [23, 26, 28] .
Although relatively few papers examine e/nNOS activation in MF function, evidence suggests a potential role for NO in phagocytosis. Stimulation of Fcg receptor (FcgR, not a GPCR) in M0 human MFs activates both eNOS and nNOS to enhances phagocytosis [23] , and the NO produced upregulates nNOS expression [23] . IFNg also up-regulates phagocytosis in an NO-dependent manner in mouse MFs [29] . Thus, Gopallawa, et al. " Bitter taste receptors stimulate phagocytosis in human macrophages through calcium, nitric oxide, and cyclic-GMP signaling" 4 we hypothesized that T2R activation of eNOS or nNOS may play a role in very early responses of MFs encountering secreted "bitter" bacterial metabolites.
Results

MFs express functional T2Rs tied to calcium signaling
Human monocytes obtained from healthy apheresis donors were differentiated to MFs by adherence culture for 12 days, confirmed by functional expression of H1 receptors (Supplementary Fig. 1 ). We observed expression of several T2Rs in unprimed (M0) MFs. Immunofluorescence using previously validated antibodies [7, 8] directed against T2R4 ( Fig. 1a) and T2R46 (Fig. 1b) , but not T2R16 (Fig. 1c) , exhibited plasma membrane staining similar to GLUT1, a major MF glucose transporter [30] . Reverse transcription (rt) PCR for T2Rs 4, 14, 38 , and 46 demonstrated expression in MFs from 3 different individuals (Fig. 1d) .
We tested a variety of T2R agonists (listed in Supplementary Table 1) using live cell calcium imaging.
We observed low-level but sustained calcium responses to denatonium benzoate, which activates eight T2Rs including T2R4 and T2R46 (Fig. 1e) [31, 32] , and to quinine, which activates 11 T2Rs including T2R14 and 46 ( Fig. 1f) [31, 32] . Bacterial T2R agonists PQS and HHQ also increased calcium ( Fig. 1g-h) . A panel of bitterants revealed responses to T2R14 agonists thujone and flufenamic acid (FFA), T2R38 agonist phenylthiocarbamide (PTC), T2R14/38 agonist 3-oxo-dodecanoylhomoserine lactone (3oxoC12HSL), and T2R14/46 agonist parthenolide [31, 32] . Peak responses are summarized in Fig. 1i and representative traces in Supplementary Fig. 2 . No response was observed with T2R16 agonist salicin, fitting with observed lack of expression ( Fig. 1c) . Stimulation of Gaq-coupled purinergic receptors with ATP was a positive control.
The responses to PTC were blocked by pertussis toxin (PTX; Fig. 1i ), which ADP ribosylates and inactivates both Gagust and Gai. Calcium responses to FFA and HHQ were inhibited by PTX and PLC inhibitor U73122, which inhibits T2R responses in airway cells [7, 8] , Gbg inhibitor gallein, which inhibits T2R responses in airway smooth muscle [33] , and inositol trisphosphate receptor (IP3R) inhibitor xestospongin C ( Fig. 1j) .
Moreover, responses to thujone, HHQ, or FFA were eliminated after intracellular calcium store depletion (thapsigargin in calcium-free solution) ( Fig. 1j) . Thus, T2R agonists activate calcium release from intracellular stores through GPCR signaling. Representative traces from experiments in Fig. 1i -j are in Supplementary   Fig. 2 and 3 . We found no differences in responses in MFs differentiated by adherence + cytokine M-CSF ( Supplementary Fig. 4 ).
To more concretely tie these results specifically to T2Rs, we used known T2R inhibitors; 4'-fluoro-6methoxyflavanone is a T2R14 and T2R39 antagonist [34] , while probenecid inhibits T2R16 and T2R38 [35] .
Calcium responses to apigenin, which activates T2R14 and T2R39, were inhibited after pretreatment with 4'fluoro-6-methoxyflavanone ( Fig. 1k) . Calcium responses to PTC were inhibited after pretreatment with probenecid ( Fig. 1l) . Representative experiments are in Supplementary Fig. 5 . Knockdown of T2R14 with pooled siRNAs inhibited responses to T2R14 agonists niflumic acid (NFA; [31, 32] ; Fig. 1m ) and HHQ ( Fig.   1m ).
MF T2R activation reduces baseline and stimulated cAMP signaling
Gopallawa, et al. "Bitter taste receptors stimulate phagocytosis in human macrophages through calcium, nitric oxide, and cyclic-GMP signaling" 6 As described above, T2R-stimulated Gai or Gagust can reduce cAMP through inhibition of adenylyl cyclase or activation of phosphodiesterase, respectively ( Fig. 2a) . Therefore, we also tested if bitter agonist stimulation reduced cAMP in MFs. We utilized an mNeonGreen-based cAMP biosensor (cADDis [36] ) in a baculovirus modified for mammalian cells (BacMam) to monitor cAMP in real time ( Fig. 2b) . Stimulation with b-adrenergic agonist isoproterenol increased cAMP ( Fig.2c ), whereas stimulation with 3oxoC12HSL, FFA, or PQS reduced cAMP (Fig. 2d) . The cAMP reductions were eliminated by PTX ( Fig. 2d) . Moreover, cAMP increases with isoproterenol were reduced in the presence of PQS or 3oxoC12HSL ( Fig. 2e) ; this was likewise eliminated by PTX ( Fig. 2f) . We confirmed these results using another cAMP biosensor, the mTurquoise2-Venus FRET-based EPAC-S H187 [37] . MFs expressing EPAC-S H187 exhibited PTX-sensitive cAMP decreases during stimulation with quinine, FFA, or 3oxoC12HSL ( Fig. 2g) .
Data demonstrate that T2Rs affect both basal and stimulated cAMP levels in MFs. Using a ratiometric Cerulean-Venus FRET-based PKA biosensor, AKAR4 [38] , we observed that PKA activity was also reduced during stimulation with PQS or FFA, and this was eliminated by PTX ( Fig. 2h) . Together, these data indicate that both arms of canonical T2R signaling appear to be active in MFs when stimulated with bitter compounds.
MF T2R calcium responses drive NO production
These T2R-activated low-level calcium responses were reminiscent of airway cells [3, 7, 8] . We tested if NO production was also downstream. M0 MFs express calcium-sensitive eNOS and/or nNOS [23] [24] [25] [26] [27] [28] . We confirmed eNOS transcript by rtPCR ( Fig. 3a) and detected eNOS and nNOS by Western ( Fig. 3b) . We used the fluorescent indicator DAF-FM to monitor production of reactive nitrogen species (RNS) in living MFs in real time. DAF-FM terminally reacts with NO and RNS derivatives, increasing fluorescence. Non-specific NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP) was used as a positive control.
Several T2R agonists, but not T2R16 agonist salicin, caused increases in DAF-FM fluorescence ( Fig.   3b ) that were blocked by PTX ( Fig. 3c ) or U73122 ( Fig. 3d ), suggesting they are downstream of T2R calcium signaling. DAF-FM fluorescence increases in response to T2R stimulation, but not SNAP, were blocked by pretreatment with NOS inhibitor L-N G -niroarginine methyl ester (L-NAME), but not inactive D-NAME, and were reduced in the presence of NO scavenger carboxy-PTIO (cPTIO; Fig. 3e ). DAF-FM results were confirmed by measuring NO decomposition products NO2and NO3in culture media ( Supplementary Fig. 6 ). Thus, DAF-FM fluorescence increases reflect NOS activation.
MF T2R signaling increases cGMP
To test the hypothesis that NO production would increase cGMP, we utilized a fluorescent cGMP biosensor (Green GENIe). We observed increases in cGMP production with denatonium benzoate or parthenolide ( Fig. 4a) , which activate calcium and NO responses, but not with salicin or sodium benzoate, which do not activate calcium or NO. The cGMP responses to FFA or PQS were blocked by L-NAME or cPTIO ( Fig. 4b) , PTX ( Fig. 4c) , or elimination of calcium ( Fig. 4d) . The cGMP increase was enhanced when MFs were co-infected with BacMam to over express soluble guanylyl cyclase (sGC), further tying these responses to NO-induced cGMP.
We used siRNA to confirm involvement of T2Rs. MFs treated with control siRNA exhibited cGMP responses to HHQ, PQS, thujone, and niflumic acid (NFA; Fig. 4f ). Treatment with a cocktail of eNOS and nNOS siRNA blocked the response to each agonist. T2R14 siRNA, but not T2R10 siRNA significantly reduced the cGMP responses to T2R14 agonists HHQ and NFA, but the response to PQS, which does not activate T2R14 [7] , remained intact (Fig. 4f) . The response to thujone, which activates both T2R14 and T2R10 [31, 32] , was slightly inhibited by either T2R14 or T2R10 siRNAs, and more fully inhibited with a cocktail of both siRNAs ( Fig. 4f ).
MF T2R activation may alter MF metabolism through combined elevations of calcium and NO.
We briefly examined if T2R stimulation had acute effects on MF metabolic state, tied to MF activation [39] , by live-cell imaging of NAD(P)H autofluorescence [40] . Ultraviolet autofluorescence increased with bitter stimulation in a PTX-and L-NAME-sensitive manner ( Supplementary Fig. 7 ), suggesting an increase in NAD(P)H levels. Increases in autofluorescence were not observed with either thapsigargin or SNAP separately to non-specifically increase Ca 2+ or NO, respectively. However, addition of thapsigargin plus SNAP robustly increased NAD(P)H autofluorescence, suggesting this is an effect of raising both Ca 2+ and NO simultaneously ( Supplementary Fig. 7) . Together, data suggest that T2R stimulation may acutely alter MF metabolism, at least short term, supporting a role for T2Rs in activation of MF immune responses.
MF T2R-driven NO signaling enhances phagocytosis
Activation of T2Rs in MFs increases intracellular calcium to activate e/nNOS and produce NO and cGMP. What consequences does this have for MF cell physiology? As mentioned above, NO was implicated in regulation of phagocytosis. We tested if T2R stimulation increased acute phagocytosis of FITC-labeled E. coli bioparticles. Incubation of MFs with FITC-E. coli in the presence of T2R bitter agonists that activated calcium and NO also increased phagocytosis by ~300% ( Fig. 5a-c) . Responses to FFA were inhibited by L-NAME, cPTIO, PKG inhibitor KT5823, or PTX ( Figure 5C ). Responses to denatonium benzoate were inhibited by PLC inhibitor U73122 or Gbg inhibitor gallein ( Fig. 5d) . A cocktail of pooled T2R14 siRNA inhibited responses to NFA or HHQ but not denatonium benzoate, which does not activate T2R14 ( Fig. 5e ). Responses to all three agonists were reduced with e/nNOS siRNAs ( Fig. 5e ).
We confirmed that we were observing phagocytosis using Staphylococcus aureus bioparticles labeled with pHrodo, a dye that fluoresces at the low pHs existing in lysosomes and phagosomes ( Fig. 6a) . MFs phagocytosed pHrodo S. aureus, evidenced by increased fluorescence, when incubated at 37 °C but not 4 °C; this was enhanced by denatonium benzoate but not sodium benzoate ( Fig. 6b and d) . Similar results were observed with FFA ( Fig. 6c and e ). Increased phagocytosis with FFA was inhibited by L-NAME, cPTIO ( Fig.   6c and e), U73122, or PTX ( Fig. 6f ). Increased phagocytosis with denatonium benzoate or quinine was also inhibited by PKG inhibitor KT5823 but not PKA inhibitor H89 (Fig. 6g) .
Others have suggested that cAMP inhibits MF phagocytosis or activation [41] [42] [43] [44] . We hypothesized that T2R-mediated cAMP decreases also facilitate phagocytosis. Baseline phagocytosis was inhibited by direct adenylyl cyclase activation by forskolin or cell permeant cAMP analogs, including 8-Br-cAMP and 8-CPT-cAMP, which activate both PKA and EPAC, and to a lesser extent by PKA-specific 6-Bnz-cAMP or EPACspecific 8-CPT-2-O-Me-cAMP ( Fig. 6h) . In contrast, cell permeant cGMP analog 8-Br-cGMP increased phagocytosis via PKG; this was inhibited by KT5823. Thus, increased cAMP likely reduces phagocytosis partially through PKA and partially through EPAC, unlike cGMP which increases phagocytosis through PKG.
Denatonium benzoate-induced phagocytosis was inhibited by forskolin or permeant cAMP analogs used above, but were not inhibited by 8-Br-cGMP ( Fig. 6i) . Together, these data suggest both the calcium/NO and cAMP arms of the T2R pathway facilitate MF phagocytosis.
NO crosstalk from airway epithelial cells may also enhance MF phagocytosis
Airway epithelial cells also make NO in response to various stimuli including T2R [3, 7] and estrogen receptor activation [45] . We hypothesized that MFs close to the airway surface may be influenced by local intercellular NO production. We designed an assay to test epithelial-MF crosstalk using PTX-treated MFs and H441 small airway epithelial cells, which produce NO in response to 17b-estradiol (E2) (Supplementary Fig.   8 ). Although MFs exhibited low-level calcium transients to 10 nM E2, these were eliminated by PTX pretreatment (Supplementary Fig. 9 ).
DAF-FM-loaded, PTX-treated MFs were incubated with unloaded H441s separated by a transwell filter in close proximity (≤1 mm; Fig. 7a ). Stimulation of H441 cells with E2 resulted in increased MF DAF-FM fluorescence ( Fig. 7b ), suggesting NO produced by the H441s translated to an increase in RNS within the MFs. Thus, epithelial NO/RNS could act as an intercellular signal. Inclusion of cPTIO or pretreatment of H441 cells with PTX or L-NAME blocked the MF DAF-FM response ( Fig. 7c) , but when MFs were pretreated with L-NAME, there was no inhibition (Fig. 7c) . Thus, the NO/RNS originated in the H441 cells. E2 had no effect when MFs were incubated in the absence of H441s (Fig. 7c) . Together, these data support the potential of airway epithelial cells to produce enough NO to be sensed by MFs in close proximity.
To test if airway epithelial NO production could act as a signal to stimulate MF phagocytosis, we measured changes in pHrodo S. aureus phagocytosis by PTX-treated MFs when H441s were stimulated with E2 ( Fig. 7d) . E2 stimulation of H441s increased MF phagocytosis ( Fig. 7e and f) , and this was blocked by H441 pretreatment with PTX or L-NAME or inclusion of cPTIO in the media (Fig. 7f) . E2 had no effect when PTX-treated MFs were incubated in the absence of H441 cells (Fig. 7f ).
Discussion
We only understand the "tip of the iceberg" of extraoral T2Rs and their signaling. We demonstrated that T2Rs in MFs may enhance phagocytosis through calcium-driven NO-activation of guanylyl cyclase to increase cGMP ( Fig. 8) . Interestingly, this is a similar pathway to airway epithelial cells [3, [7] [8] [9] 46] , but the physiological output is different. In ciliated cells, the pathway controls cilia beating; in MFs, it regulates phagocytosis. Both processes are critical for innate defense, supporting a role for T2Rs as immune receptors.
In MFs encountering bitter bacterial agonists at sites of infection, activated T2Rs may "rev up" acute phagocytic activity while likely simultaneous toll-like receptor (TLR) stimulation up-regulates expression of iNOS and antimicrobial proteins such as lysozyme to further combat infection. Of note, T2Rs also respond to a variety of natural plant compounds associated with complementary medicines, including flavonoids [8, [47] [48] [49] , as well as common clinical drugs [50, 51] . Activation of extraoral T2Rs in MFs may underlie some effects of homeopathic plant-based treatments or off-target drug effects.
This study also suggests that NO produced by airway epithelial cells could increase MF phagocytosis in a paracrine fashion ( Fig. 8) . NO produced during activation of T2Rs in airway epithelial cells [3, 7] may influence immune cells or amplify immune responses. NO may regulate phagocytosis via several mechanisms, including ADP-ribosylation of actin to regulate cytoskeletal polymerization, and pseudopodia formation, and phagocytosis in mouse peritoneal MFs [52] . In Raw 264.7 mouse MF-like cells, NO acutely regulates actin organization through cGMP in combination with Ca 2+ /calmodulin [53] , and cGMP/PKG may be important in phagocytic responses during TLR2 stimulation in THP-1 monocytic leukemia cells [54] .
It is important to better understand e/nNOS and cGMP signaling in Mfs beyond phagocytosis.
Production of cGMP was linked to protection against toxicity of peroxynitrite (ONOO-) or oxidized LDL [55] , reduction of cytokine release during LPS stimulation [56] or high fat exposure [57, 58] , and promotion of wound healing [59] . NO itself may be anti-inflammatory by activation of PPARg, antagonizing NOX2 production of reactive oxygen species [60] , or attenuation of NF-kB and activation of Nrf2 transcription factors [61] .
However, MFs from eNOS knockout mice exhibit reduced NO production, NF-kB activation, and iNOS upregulation during LPS stimulation [28] .
Interestingly, T2R-induced lowering of cAMP levels may be another mechanism to enhance phagocytosis; cAMP elevation through prostaglandins decreases phagocytosis in human MFs [41] and other inhibitory effects of cAMP have been reported [42] [43] [44] . Canonical T2R signaling is driven by Ca 2+ downstream of Gbg activation of PLC. The decrease in cAMP by Ggust was proposed to accentuate calcium signaling via type III IP3Rs in taste cells [62, 63] , but data supporting this mechanism are limited. Increased cAMP and PKA phosphorylation of IP3R is more often reported to enhance calcium signaling [64] , though PKA phosphorylation of type III IP3R has been suggested to slow kinetics of calcium release in pancreatic acinar cells [65] . If taste cell signaling is primarily driven by calcium [66] , why have T2Rs not evolved to couple to Gq instead of Ggust or Gopallawa 
Materials and Methods
Reagents and solutions
Unless indicated, all reagents and solutions were as described [7, 8, 67, 68] . Full details of materials, reagents, and solution compositions are in the Supplementary Material. Bitter agonists used and known cognate T2Rs are in Supplementary Table 1 . Immunofluorescence (IF) microscopy was carried out as described [7, 8, 67, 68] , with more details in the Supplementary Material. 
Phagocytosis assays
For microscopy, MFs on chambered coverglasses were incubated with heat-killed FITC-labeled E. coli bioparticles at 250 µg/ml (strain K-12; Vybrant phagocytosis assay kit; ThermoFisher Scientific) in phenol redfree, low glucose DMEM ± bitter agonists or inhibitors for 15 min at 37°C. For microscopy, extracellular FITC was quenched with trypan blue and cells were washed ≥5x in PBS to remove residual extracellular FITC-E. For plate reader assays, MFs on microplates were incubated similarly as above with 500 µg/ml FITC-E. coli. As phagocytosis was eliminated at 4 °C and almost completely eliminated at room temperature, we recorded fluorescence from living cells at room temperature immediately after the 15 min incubation with FITC-E. coli. Extracellular FITC was quenched with trypan blue, and fluorescence recorded on a Spark 10M plate reader (Tecan; 485 ex, 535 em). Phagocytosis assays were carried out similarly using 125 µg/ml pHrodo-S. Filters containing 100 µL HBSS on the apical side were transferred into the 24 well plates containing H441 cells and a small amount of HEPES-buffered HBSS (200 µL) at the time of the assay. MFs were pretreated with PTX (100 ng/ml) for ~18 hrs in media (37°C, 5% CO2), followed by copious washing with HBSS to remove residual PTX before co-incubation with H441s. Similarly, DAF-FM loading of MFs was performed prior to coincubation with H441s. Addition of fluorescently-labeled bacteria to MFs on transwells was done at the time of assay start. Immediately after, 100 µL of a 3x E2 solution in HBSS was added to the basolateral side to stimulate H441 NO production and the 24 well plate was then incubated at 37°C.
Data analysis and statistics
Statistical significance was determined in GraphPad Prism as indicated in figure legends; p <0.05 was considered statistically significant. Other analyses were performed in Excel. Data are presented as mean ± SEM. Data points in bar graphs are ≥3 independent experiments using cells from ≥2-3 donors. While circulating BMDMs differentiate into Mφs that are not exactly the same as the alveolar Mφs that populate the airways at baseline, (31) (32) (33) BMDM-derived Mφs are often used as surrogates for alveolar Mφs and are nonetheless themselves important for infections all over the body. BMDMs migrate to sites of infection and inflammation, including the airway. BMDM-derived Mφs are particularly important in conditions of chronic inflammation, like chronic rhinosinusitis. Dysfunction of both alveolar and BMDM-derived Mφs is implicated in pathogenesis of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. (34) (35) (36) Our data suggest that T1Rs and T2Rs may stimulate immune responses from Mφs, and suggest that T1Rs/T2R-targeted therapeutics (which could be delivered via inhaler or nasal spray) may be beneficial against infections associated with these diseases. However, we need to do the experiments outlined in this proposal to better understand how T1Rs and T2Rs contribute to Mφs function. Because of the differences in numbers of T2Rs in human (~25 T2Rs) and mouse (~35 T2Rs) and lack of clear othologues, (19) experiments need to be done in human cells as proposed here.
We have access to large amounts of primary human BMDMs at Penn and began studying M0 (unpolarized/unprimed) Mφs ( Fig. 2A) . Studies proposed here will also examine T1R/T2R physiology in M1 and M2 Mφs and dendritic cells differentiated from BMDMs using defined cytokines. (37) (38) (39) (40) (41) BMDMs are differentiated to M0 Mφs by 10-day culture in media + human serum ( Fig.  2A) . We have found no differences between Mφs differentiated by adherence ± the cytokine M-CSF (as reported by others (42) (43) (44) ), but we are acquiring data from both conditions. For simplicity, data shown here are from Mφs differentiated by adherence only. Differentiation to Mφs was confirmed by functional expression of markers, including histamine H1 receptors (45, 46) (monocytes express H2 receptors), determined by Ca 2+ imaging and specific antagonists (cetirizine and ranitidine, respectively; not shown).
M0 Mφs express several T2Rs (Fig. 2B-C) and T1R3 (Fig.  2D) localized to the plasma membrane. When Mφs were loaded with fura-2 to track changes in intracellular Ca 2+ , we noted lowlevel Ca 2+ responses to a variety of bitter agonists ( Fig. 3A-B ; next page). Responses were blocked by pertussis toxin (PTX; Fig 3C) , which ADP-ribosylates and inactivates Gαs that can couple to T2Rs (G i (47) and/or G gustducin (48) (49) (50) ). Responses to bacterial T2R14 agonist HHQ were blocked by T2R14 antagonist 4-fluoro-6methoxy-flavanone (15, 51) (Fig. 3D) . Similar Ca 2+ responses were observed with T1R2/3 (sweet receptor) agonist sucralose (52) and were blocked by T1R3 antagonist lactisole (Fig 3E) . (53) As would be expected from a G i -or G gust -coupled response (Fig 1b) , a cAMP decrease was also observed in Mφs transfected with a cAMP-sensitive fluorescent protein biosensor (EPAC-SH187 (18, 54) ). This cAMP decrease was blocked by PTX pretreatment ( Fig. 3F) . Similar results were observed with a mammalianmodified baculovirus (BacMam; Autographa californica [AcMNPV] pseudotyped to infect mammalian cells)-expressed cAMP biosensor (cADDis (55) ; Montana Molecular, Bozeman MT; not shown). BacMam resulted in high transduction efficiency for Mφs (~30-50% vs 1-2% with Effectene or FuGene and pcDNA). Future experiments will take advantage of BacMam vectors. (56) As Mφ T2R responses were reminiscent of airway cells, (6, 15, 18) we tested if NO was downstream. Most Mφ studies focus on NO production via mRNA/protein upregulation of inducible iNOS during Mφ activation by LPS ± IFNγ. (57) (58) (59) However, iNOS is not expressed in monocytes and unstimulated M0 Mφs ( (58) (59) (60) and our own data, not shown). Constitutive expression of Ca 2+ -sensitive 
PQS and HHQ decrease baseline and stimulated cAMP levels in lung epithelial cells
The other arm of the canonical T2R signaling pathway (Fig.  3a) is G␣ gust , a G␣ protein of the transducin family (80 -83) which activates phosphodiesterase (PDE). Several airway cell lines have been reported to express G␣ gust (72, 84), although G␣ i isoforms, which inhibit adenylyl cyclases, couple to T2Rs in airway smooth muscle (85). To test whether quinolones activated a G␣ gust /G␣ i pathway, we monitored cAMP dynamics in real time in living cells using a high-affinity fourth-generation Turquoise (CFP)/Venus (YFP) FRET-based EPAC cAMP indicator, EPAC-S H187 (86). This construct was previously used to image a decrease in baseline cAMP levels in HEK293T cells expressing G␣ i/o -coupled -opioid receptors (87). BEAS-2B cells transfected with EPAC-S H187 and stimulated with PQS or y cell lines. a, diagram of canonical T2R receptor signaling, which involves G␣-gustducin (G␣ gust ) lowering of cAMP in addition to G␤␥ activation of PLC␤2, which generates IP 3 DAF-FM increases were inhibited by treatment of H441s with PTX (100 ng/ml; 18 hrs) or L-NAME (10 µM, 30 min) or in the presence of cPTIO (10 µM). Treatment of MFs with L-NAME did not alter responses, and there was no response to E2 in the absence of H441s. d Diagram of experimental design for e-f. PTXpretreated MFs incubated with pHrodo-labeled S. aureus were placed in close proximity (<1 mm) to H441s. e Representative images of fluorescence increases with PTX-pretreated MFs with H441s stimulated as indicated for 30 min. f Bar graph of MFs fluorescence increases quantified by microscopy with stimulations as indicated. E2 increased MF phagocytosis that was blocked by PTX, L-NAME, cPTIO, or absence of H441s. Bar graphs are mean ± SEM with data points shown from independent experiments using cells from at least 2 individual donors (≥2 independent experiments per donor). Significance by one-way ANOVA with Bonferonni posttest with each bar compared with its respective HBSS only control; ** p<0.01. Figures in a and d 
